How many shots are in the pneumonia vaccine?

Written by Li Jiao Yan
Neonatology
Updated on September 02, 2024
00:00
00:00

Currently, there are two general types of vaccines for preventing pneumococcal pneumonia. One type is the 23-valent vaccine, suitable for high-risk populations over two years old. The other type includes the 7-valent or 13-valent vaccines, which are for preventing pneumococcal infections in infants under two years old. Infants under two usually follow a "three plus one" vaccination regimen, which involves three primary immunization doses with at least one month between each dose, followed by a booster shot. Additionally, adults over two years old or other high-risk groups are advised to take the 23-valent vaccine, which requires only a single dose. However, those who are frail or have poor immune responses may need a second booster dose five years after the initial vaccination.

Other Voices

doctor image
home-news-image
Written by Wang Chun Mei
Pulmonology
1min 14sec home-news-image

Do you have a runny nose with pneumonia?

In clinical settings, pneumonia patients exhibit varying accompanying symptoms depending on the type of pneumonia. Particularly in very young infants, the early symptoms might primarily include nasal congestion, runny nose, sneezing, and even fever, without obvious coughing symptoms. In some newborns, pneumonia can be diagnosed through auscultation at this stage. In adults, certain types of pneumonia, such as those caused by viral infections, may not receive timely and effective anti-infective or antiviral treatment initially. In these cases, the condition can worsen and spread, leading to pneumonia, with some patients also experiencing symptoms of a runny nose. Of course, conditions like most cases of mycoplasma pneumonia, bacterial pneumonia, and lung abscesses that cause pulmonary inflammation usually do not involve a runny nose. Therefore, in clinical practice, if pneumonia is accompanied by a runny nose, it is usually due to specific circumstances of the illness.

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
1min 24sec home-news-image

How to completely cure pneumonia in children?

Childhood pneumonia is mainly due to the weaker resistance of children, who are then subjected to the invasion of pathogens such as bacteria, viruses, or other agents like chlamydia and mycoplasma, leading to inflammation of the alveoli. Generally, the treatment of pneumonia is mainly targeted at its pathogens. For instance, antiviral treatment is administered for viral infections, antibacterial and anti-inflammatory treatments are required for bacterial infections, and specific antibiotics such as azithromycin or erythromycin are used for mycoplasma infections. For other types like tuberculosis and some other fungal pneumonias, specific treatments targeting those pathogens are also necessary. If the baby clearly has symptoms like wheezing or difficulty in breathing, symptomatic treatment is required. Therefore, pneumonia in children is mainly treated based on the cause, and as long as the course of treatment is sufficient, it can be cured completely. However, even after recovery, it does not mean a child will never contract pneumonia again. If the child has weak immunity or is in a high-risk environment with exposure to other patients with pneumonia cough, they might be infected again.

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
50sec home-news-image

Can pneumonia vaccines prevent mycoplasma pneumonia?

There are currently two types of pneumonia vaccines available domestically: the 23-valent polysaccharide vaccine and the 7-valent or 13-valent vaccines. These vaccines primarily prevent infections caused by certain serotypes of Streptococcus pneumoniae. The pneumonia vaccines cannot prevent Mycoplasma pneumonia, as Mycoplasma and Streptococcus pneumoniae are two different types of pathogens and do not share the same antibodies for protective effects. Thus, the pneumonia vaccines are mainly for preventing diseases related to Streptococcus pneumoniae infections, and are ineffective against Mycoplasma pneumonia.

doctor image
home-news-image
Written by Yang Feng
Pulmonology
45sec home-news-image

Are the symptoms of pneumonia severe?

Whether pneumonia symptoms are severe needs to be based on the patient's clinical presentation and the extent of infection seen in imaging studies. Through these assessments, one can generally determine the severity of the patient's infection and thus comment on the severity of the disease. Pneumonia is generally most commonly seen due to bacterial infections, but there are also instances of fungal, mycoplasma, and viral infections in clinical settings, which have become relatively more common than before. When these infections occur, it is necessary to identify the pathogen, and then choose an antibiotic susceptible to the pathogen based on bacterial culture and sensitivity tests. Generally, lung infections can be cured.

doctor image
home-news-image
Written by Wang Xiang Yu
Pulmonology
1min 24sec home-news-image

Can pneumonia vaccines prevent mycoplasma pneumonia?

Can pneumonia vaccines prevent Mycoplasma infections? First, we need to understand what pneumonia vaccines are. In our country, the most commonly used pneumonia vaccines are aimed at Streptococcus pneumoniae, which are divided into polysaccharide vaccines and conjugate vaccines. Polysaccharide vaccines are mainly suitable for individuals over two years old and include the 23-valent polysaccharide vaccine. This vaccine can prevent infections caused by twenty-three serotypes that often lead to S. pneumoniae infections, with over 90% of pneumonia caused by these twenty-three serotypes. However, the 23-valent polysaccharide vaccine does not prevent infections caused by other serotypes of S. pneumoniae. Additionally, the conjugate vaccine only prevents infections caused by either seven or thirteen serotypes. Since Mycoplasma is neither a bacterium nor a virus, it cannot be prevented by pneumonia vaccines, and currently, there is no vaccine available specifically for Mycoplasma infections.